Cobio Diagnostics
Cobio Diagnostics: Pioneering biotech firm specializing in bacterial identification and antibiotic resistance testing.
Founded
2016Cobio Diagnostics: Pioneering biotech firm specializing in bacterial identification and antibiotic resistance testing.
Cobio Diagnostics, founded in 2016 and based in Golden, Colorado, is a biotechnology company dedicated to developing advanced diagnostics for bacterial identification and phenotypic antibiotic resistance testing. The company's core mission is to combat the growing threat of antibiotic resistance, which poses significant risks to global health, food security, and development. Cobio Diagnostics offers innovative diagnostic solutions aimed at accurately identifying bacterial infections and determining their resistance profiles, thereby enabling more effective treatment strategies.
Notable figures affiliated with Cobio Diagnostics include experts in biotechnology and healthcare, although specific names are not provided. The company has attracted attention from investors interested in addressing critical public health challenges. Key achievements include the development of cutting-edge diagnostic tools that have the potential to significantly reduce the incidence of antibiotic-resistant infections. Cobio Diagnostics' impact lies in its contribution to improving patient outcomes and supporting global efforts to manage antibiotic resistance.
Companies similar to Cobio Diagnostics include BioAmp diagnostics, Specific Diagnostics, FYR Diagnostics and Day Zero Diagnostics.
Cobio Diagnostics was founded in 2016.
Cobio Diagnostics' headquarters is located in Golden, CO, US.
Cobio Diagnostics' most recent funding round was for $256k (USD) in March 2021.
As of Mar 31, 2021, Cobio Diagnostics has raised a total of $256k (USD).
Cobio Diagnostics has 6 employees as of Feb 4, 2024.
FYR Diagnostics
fyrdiagnostics.com
